These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23169297)

  • 1. Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.
    Kachroo N; Valencia T; Warren AY; Gnanapragasam VJ
    Br J Cancer; 2013 Feb; 108(3):597-601. PubMed ID: 23169297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer.
    Darby S; Sahadevan K; Khan MM; Robson CN; Leung HY; Gnanapragasam VJ
    Oncogene; 2006 Jul; 25(29):4122-7. PubMed ID: 16474841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role and expression of FRS2 and FRS3 in prostate cancer.
    Valencia T; Joseph A; Kachroo N; Darby S; Meakin S; Gnanapragasam VJ
    BMC Cancer; 2011 Nov; 11():484. PubMed ID: 22078327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
    Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
    Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
    Darby S; Murphy T; Thomas H; Robson CN; Leung HY; Mathers ME; Gnanapragasam VJ
    Br J Cancer; 2009 Dec; 101(11):1891-9. PubMed ID: 19888221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer: a working hypothesis.
    Assinder SJ; Beniamen D; Lovicu FJ
    Biomed Res Int; 2015; 2015():827462. PubMed ID: 26075267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
    Yang N; Wang L; Chen X; Liu J; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.
    Lin B; Utleg AG; Gravdal K; White JT; Halvorsen OJ; Lu W; True LD; Vessella R; Lange PH; Nelson PS; Hood L; Kalland KH; Akslen LA
    Clin Cancer Res; 2008 Mar; 14(5):1397-406. PubMed ID: 18316561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
    Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
    Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LDHA suppresses tumor progression in prostate cancer.
    Xian ZY; Liu JM; Chen QK; Chen HZ; Ye CJ; Xue J; Yang HQ; Li JL; Liu XF; Kuang SJ
    Tumour Biol; 2015 Sep; 36(10):8093-100. PubMed ID: 25983002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
    Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
    Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
    You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
    J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.